Biologics in dermatology: What does the future hold?
As the first dermatological biological treatment, infliximab was first used in the treatment of psoriasis in 2001. Since that time many biological agents have come into use for dermatological diseases and developments in this area are still ongoing. The most important feature of biological treatments is that the treatment must be target directed. In the light of technological developments, the concept has emerged of treatment directed to a patient-specific target.